한글목차

세포 면역요법 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 65억 6,000만 달러에서 2026년에는 74억 8,000만 달러로, CAGR 14.1%로 성장할 것으로 예상됩니다. 지난 수년간의 성장은 초기 CAR-T 치료의 성공, 미충족 종양학 수요, 연구 자금 증가, 규제 당국의 승인, 산학협력 등에 기인한 것으로 분석됩니다.

세포 면역요법 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 13.7%의 CAGR로 125억 달러에 달할 전망입니다. 예측 기간의 성장 요인으로는 고형암 영역으로의 확장, NK세포 치료의 혁신, 확장 가능한 제조 기술, 지원적인 규제 프레임워크, 종양학 분야에 대한 투자 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 CAR-T 세포 치료의 급속한 성장, 동종 세포 치료의 확대, 혈액 악성 종양에서의 사용 증가, T 세포 공학의 발전, 임상시험 활동의 활성화 등을 들 수 있습니다.

암 발병률의 증가는 향후 몇 년 동안 세포 면역요법 시장의 성장을 견인할 것으로 예상됩니다. 암은 체내에서 비정상적인 세포가 통제할 수 없을 정도로 증식하고 확산되는 일련의 질병군입니다. 암 환자 증가는 주로 고령화, 생활습관, 검진 및 진단 기술의 발전에 기인합니다. 환경적 노출과 유전적 소인도 발병률 상승에 크게 기여하고 있습니다. 세포면역치료는 종양세포를 특이적으로 표적화하여 면역체계의 암에 대한 반응을 높여 생존율 향상에 기여합니다. 다른 치료법과 병용하여 암 발생률과 재발률을 낮추는 데 기여할 수 있습니다. 예를 들어, 2024년 3월 영국에 본사를 둔 암 연구 기관인 MAC Clinical Research가 발표한 보고서에 따르면, 영국의 암 환자 수는 현재 약 300만 명에서 2025년까지 350만 명, 2030년까지 400만 명, 2040년까지 530만 명으로 증가할 것으로 예측하고 있습니다. 증가할 것으로 예측됩니다. 그 결과, 암 발병률의 증가는 세포면역치료 시장의 성장을 촉진하고 있습니다.

세포 면역요법 시장에서 사업을 전개하고 있는 주요 기업들은 치료 효과 향상과 적용 범위 확대를 목표로 한 면역치료제 등 기술 혁신 개발에 주력하고 있습니다. 중점 분야는 맞춤형 의료, 병용요법, 환자 결과 개선을 위한 확장 가능한 제조 기술 등입니다. 면역요법이란, 특히 암과 같은 질병과 싸우기 위해 체내의 면역체계를 활용하는 치료법입니다. 면역반응을 강화하거나 특정 세포에 대한 면역 활성을 높이는 표적 치료제를 시행하는 것 등이 포함됩니다. 예를 들어, 2023년 12월 인도에 본사를 둔 헬스케어 서비스 제공업체인 Max Healthcare Institute Limited는 유전자 조작된 T세포를 사용하여 암세포를 정밀하게 표적화하여 제거하는 획기적인 암 치료법인 CAR-T 세포 치료법을 강조했습니다. 이 치료법은 특히 치료 저항성 혈액암에 대해 장기적인 관해율을 제공함과 동시에 건강한 조직 손상을 최소화합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Cellular immunotherapy is a type of immunotherapy in which a patient is given T cells, a type of immune cell, to help the body fight diseases such as cancer. It is an advanced form of treatment that harnesses the body's immune system to target cancer.

The main therapies in cellular immunotherapy include tumor-infiltrating lymphocyte (TIL) therapy, engineered T cell receptor (TCR) therapy, chimeric antigen receptor (CAR) T cell therapy, and natural killer (NK) cell therapy. Tumor-infiltrating lymphocyte (TIL) therapy is a form of adoptive cellular therapy that involves isolating lymphocytes that have infiltrated tumors, expanding and culturing them in vitro, and then reintroducing them into patients for treatment. The primary indications include B-cell malignancies, prostate cancer, renal cell carcinoma, liver cancer, non-Hodgkin lymphoma, among others, and it is applied in the treatment of prostate cancer, breast cancer, skin cancer, ovarian cancer, brain tumors, lung cancer, and additional types of cancer.

Tariffs have raised the cost of imported cell therapy equipment, single use systems, and specialized reagents used in advanced therapy manufacturing. These impacts are most evident in Europe and Asia, where cell therapy developers rely on cross border sourcing for critical inputs. Rising tariff related expenses have increased production costs and influenced investment planning for cell based therapies. This has affected scale up timelines and capacity expansion decisions. However, tariffs are also encouraging regional manufacturing capabilities, local supplier ecosystems, and greater self sufficiency in advanced therapy production over the long term.

The cellular immunotherapy market research report is one of a series of new reports from The Business Research Company that provides cellular immunotherapy market statistics, including cellular immunotherapy industry global market size, regional shares, competitors with a cellular immunotherapy market share, detailed cellular immunotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the cellular immunotherapy industry. This cellular immunotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cellular immunotherapy market size has grown rapidly in recent years. It will grow from $6.56 billion in 2025 to $7.48 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to success of early car-t therapies, unmet oncology needs, research funding growth, regulatory approvals, academic-industry collaboration.

The cellular immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $12.5 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to expansion into solid tumors, innovation in nk cell therapy, scalable manufacturing technologies, supportive regulatory frameworks, increased oncology investment. Major trends in the forecast period include rapid growth of car-t cell therapies, expansion of allogeneic cell therapies, increasing use in hematologic malignancies, advancements in t cell engineering, rising clinical trial activity.

The increasing prevalence of cancer is expected to drive the expansion of the cellular immunotherapy market in the coming years. Cancer comprises a group of diseases characterized by the uncontrolled growth and spread of abnormal cells within the body. The rise in cancer cases is largely attributed to an aging population, lifestyle choices, and advancements in screening and diagnosis. Environmental exposures and genetic predispositions also significantly contribute to the increasing incidence. Cellular immunotherapy enhances the immune system's response against cancer by specifically targeting tumor cells, thereby improving survival rates. When used alongside other treatments, this approach may contribute to a reduction in cancer incidence and recurrence. For example, in March 2024, MAC Clinical Research, a UK-based cancer research organization, reported that the estimated number of people living with cancer in the United Kingdom is expected to rise from around 3 million currently to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the rising prevalence of cancer is propelling the growth of the cellular immunotherapy market.

Major companies operating in the cellular immunotherapy market are concentrating on developing technological innovations such as immunotherapy to improve treatment effectiveness and broaden its applications. Their focus areas include personalized medicine, combination therapies, and scalable manufacturing to enhance patient outcomes. Immunotherapy is a treatment that leverages the body's immune system to combat diseases, particularly cancer. It may involve enhancing immune responses or delivering targeted therapies to boost immune activity against specific cells. For example, in December 2023, Max Healthcare Institute Limited, an India-based healthcare service provider, highlighted CAR-T cell therapy, a groundbreaking cancer treatment that uses genetically engineered T cells to precisely target and eliminate cancer cells, offering a personalized strategy. This therapy provides long-lasting remission rates, especially for treatment-resistant blood cancers, while minimizing harm to healthy tissues.

In January 2023, AstraZeneca, a UK-based pharmaceutical company, acquired Neogene Therapeutics for an undisclosed amount. Through this acquisition, AstraZeneca intends to strengthen its oncology portfolio and accelerate the development of innovative T-cell receptor therapies for solid tumors via Neogene Therapeutics. Neogene Therapeutics, Inc., a US-based biotechnology firm, specializes in personalized cellular immunotherapy, engineering T-cells to specifically target cancer cells.

Major companies operating in the cellular immunotherapy market are Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp, AstraZeneca plc, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics plc, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc., Juno Therapeutics Inc., Celgene Corporation, Bluebird Bio Inc., Tmunity Therapeutics Inc., Atara Biotherapeutics Inc., Fate Therapeutics Inc., Precision Biosciences Inc., Allogene Therapeutics Inc., CRISPR Therapeutics AG, Sangamo Therapeutics Inc., Intellia Therapeutics Inc., Editas Medicine Inc., Caribou Biosciences Inc., Mammoth Biosciences Inc., Synthego Corporation

North America was the largest region in the cellular immunotherapy market in 2025. The regions covered in the cellular immunotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cellular immunotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cellular immunotherapy market includes revenues earned by entities by inventing, developing, administering, and understanding engineered immune effector cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cellular Immunotherapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cellular immunotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cellular immunotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cellular immunotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy; Engineered T Cell Receptor (TCR) Therapy; Chimeric Antigen Receptor (CAR) T Cell Therapy; Natural Killer (NK) Cell Therapy
• 2) By Primary Indication: B-cell Malignancies; Prostate Cancer; Renal Cell Carcinoma; Liver Cancer; Non-Hodgkin lymphoma; Other Primary Indications
• 3) By Application: Prostate Cancer; Breast Cancer; Skin Cancer; Ovarian Cancer; Brain Tumor; Lung Cancer; Other Applications
• Subsegments:
• 1) By Tumour-Infiltrating Lymphocyte (TIL) Therapy: Autologous TIL Therapy; Allogeneic TIL Therapy
• 2) By Engineered T Cell Receptor (TCR) Therapy: Alpha-Beta TCR Therapy; Gamma-Delta TCR Therapy
• 3) By Chimeric Antigen Receptor (CAR) T Cell Therapy: Autologous CAR T Cell Therapy; Allogeneic CAR T Cell Therapy; CAR T Cell Therapy For Solid Tumors; CAR T Cell Therapy For Hematologic Malignancies
• 4) By Natural Killer (NK) Cell Therapy: Autologous NK Cell Therapy; Allogeneic NK Cell Therapy; NK Cell Therapy With Engineered Modifications
• Companies Mentioned: Novartis International AG; Gilead Sciences Inc.; Apac Biotech; Dendreon Pharmaceuticals LLC; JW CreaGene Co. Ltd; Green Cross Corp; AstraZeneca plc; Bristol Myers Squibb Company; Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Adicet Bio Inc.; ResTORbio Inc.; Celyad SA; Merck KGaA; GlaxoSmithKline plc.; Johnson & Johnson; Adaptimmune Therapeutics plc; AVROBIO Inc.; Cellular Biomedicine Group Inc.; Kite Pharma Inc.; Juno Therapeutics Inc.; Celgene Corporation; Bluebird Bio Inc.; Tmunity Therapeutics Inc.; Atara Biotherapeutics Inc.; Fate Therapeutics Inc.; Precision Biosciences Inc.; Allogene Therapeutics Inc.; CRISPR Therapeutics AG; Sangamo Therapeutics Inc.; Intellia Therapeutics Inc.; Editas Medicine Inc.; Caribou Biosciences Inc.; Mammoth Biosciences Inc.; Synthego Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Cellular Immunotherapy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Cellular Immunotherapy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Cellular Immunotherapy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Cellular Immunotherapy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rapid Growth Of Car-T Cell Therapies
  • 4.2.2 Expansion Of Allogeneic Cell Therapies
  • 4.2.3 Increasing Use In Hematologic Malignancies
  • 4.2.4 Advancements In T Cell Engineering
  • 4.2.5 Rising Clinical Trial Activity

5. Cellular Immunotherapy Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Cancer Treatment Centers
• 5.3 Specialty Oncology Clinics
• 5.4 Academic Medical Centers
• 5.5 Clinical Research Institutes

6. Cellular Immunotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cellular Immunotherapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Cellular Immunotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Cellular Immunotherapy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Cellular Immunotherapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Cellular Immunotherapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cellular Immunotherapy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cellular Immunotherapy Market Segmentation

• 9.1. Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy
• 9.2. Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications
• 9.3. Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications
• 9.4. Global Cellular Immunotherapy Market, Sub-Segmentation Of Tumour-Infiltrating Lymphocyte (TIL) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Autologous TIL Therapy, Allogeneic TIL Therapy
• 9.5. Global Cellular Immunotherapy Market, Sub-Segmentation Of Engineered T Cell Receptor (TCR) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Alpha-Beta TCR Therapy, Gamma-Delta TCR Therapy
• 9.6. Global Cellular Immunotherapy Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Autologous CAR T Cell Therapy, Allogeneic CAR T Cell Therapy, CAR T Cell Therapy For Solid Tumors, CAR T Cell Therapy For Hematologic Malignancies
• 9.7. Global Cellular Immunotherapy Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Autologous NK Cell Therapy, Allogeneic NK Cell Therapy, NK Cell Therapy With Engineered Modifications

10. Cellular Immunotherapy Market Regional And Country Analysis

• 10.1. Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cellular Immunotherapy Market

• 11.1. Asia-Pacific Cellular Immunotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cellular Immunotherapy Market

• 12.1. China Cellular Immunotherapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cellular Immunotherapy Market

• 13.1. India Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cellular Immunotherapy Market

• 14.1. Japan Cellular Immunotherapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cellular Immunotherapy Market

• 15.1. Australia Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cellular Immunotherapy Market

• 16.1. Indonesia Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cellular Immunotherapy Market

• 17.1. South Korea Cellular Immunotherapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cellular Immunotherapy Market

• 18.1. Taiwan Cellular Immunotherapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cellular Immunotherapy Market

• 19.1. South East Asia Cellular Immunotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cellular Immunotherapy Market

• 20.1. Western Europe Cellular Immunotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cellular Immunotherapy Market

• 21.1. UK Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cellular Immunotherapy Market

• 22.1. Germany Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cellular Immunotherapy Market

• 23.1. France Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cellular Immunotherapy Market

• 24.1. Italy Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cellular Immunotherapy Market

• 25.1. Spain Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cellular Immunotherapy Market

• 26.1. Eastern Europe Cellular Immunotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cellular Immunotherapy Market

• 27.1. Russia Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cellular Immunotherapy Market

• 28.1. North America Cellular Immunotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cellular Immunotherapy Market

• 29.1. USA Cellular Immunotherapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cellular Immunotherapy Market

• 30.1. Canada Cellular Immunotherapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cellular Immunotherapy Market

• 31.1. South America Cellular Immunotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cellular Immunotherapy Market

• 32.1. Brazil Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cellular Immunotherapy Market

• 33.1. Middle East Cellular Immunotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cellular Immunotherapy Market

• 34.1. Africa Cellular Immunotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cellular Immunotherapy Market Regulatory and Investment Landscape

36. Cellular Immunotherapy Market Competitive Landscape And Company Profiles

• 36.1. Cellular Immunotherapy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Cellular Immunotherapy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Cellular Immunotherapy Market Company Profiles
  • 36.3.1. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Apac Biotech Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Dendreon Pharmaceuticals LLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. JW CreaGene Co. Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Cellular Immunotherapy Market Other Major And Innovative Companies

• Green Cross Corp, AstraZeneca plc, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics plc, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc.

38. Global Cellular Immunotherapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cellular Immunotherapy Market

40. Cellular Immunotherapy Market High Potential Countries, Segments and Strategies

• 40.1 Cellular Immunotherapy Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Cellular Immunotherapy Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Cellular Immunotherapy Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer